Danaher Corporation $DHR Shares Newly Acquired by Gunderson Capital Management LLC

Gunderson Capital Management LLC acquired a new stake in Danaher Corporation (NYSE:DHR) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 3,453 shares of the conglomerate’s stock, valued at approximately $765,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. EP Wealth Advisors LLC acquired a new position in shares of Danaher in the 2nd quarter worth approximately $3,807,000. Puzo Michael J bought a new position in Danaher during the 2nd quarter valued at about $8,624,000. Madison Asset Management LLC acquired a new position in Danaher in the second quarter valued at about $85,451,000. First Nebraska Trust Co bought a new stake in Danaher during the second quarter worth about $14,106,000. Finally, Colton Groome Financial Advisors LLC acquired a new stake in Danaher during the 3rd quarter valued at $592,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

DHR opened at $231.52 on Friday. The business has a 50 day moving average of $213.55 and a 200-day moving average of $195.74. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a market cap of $162.76 billion, a price-to-earnings ratio of 41.12, a PEG ratio of 2.82 and a beta of 0.76. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.77 EPS. On average, equities research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on DHR. TD Cowen raised their price objective on shares of Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a research report on Tuesday. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Stifel Nicolaus reduced their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. The Goldman Sachs Group boosted their target price on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Finally, Morgan Stanley increased their target price on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a report on Monday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $235.41.

Key Headlines Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher and NVIDIA announced an AI collaboration to combine Danaher’s scientific instruments, laboratory workflows, automation technology and software with NVIDIA’s accelerated computing and AI capabilities. The partnership is intended to advance autonomous science and speed drug discovery and other laboratory research. Danaher Collaborates with NVIDIA to Advance Autonomous Science
• Positive Sentiment: Danaher is also preparing to launch its first AI-powered autonomous laboratory, targeted to operate at commercial scale in early 2027. The initiative could support longer-term growth in laboratory automation and strengthen the company’s position in AI-enabled life-science research. How to Invest in AI Drug Discovery
• Positive Sentiment: Multiple Zacks reports say Danaher has a favorable combination of earnings-estimate trends and Earnings ESP, suggesting potential for the company to exceed consensus estimates in its next quarterly report. Danaher has also recently demonstrated earnings momentum, with its latest reported quarter exceeding both EPS and revenue expectations. Will Danaher Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: Danaher is projected to announce earnings on Wednesday. Investors will be watching revenue growth, management’s outlook and whether diagnostics and life-sciences demand support the anticipated improvement in earnings. Danaher Projected to Announce Earnings

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.